{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:19:42Z","timestamp":1793859582930,"version":"4.6.1"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100022424","name":"Ministry of Scientific and Technological Development, Higher Education and Information Society","doi-asserted-by":"publisher","award":["No.242102311286"],"award-info":[{"award-number":["No.242102311286"]}],"id":[{"id":"10.13039\/501100022424","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12015-025-10931-7","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T02:48:05Z","timestamp":1751251685000},"page":"1883-1900","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Induced Pluripotent Stem Cells Derived Cellular Models for Investigating Parkinson\u2019s Disease Pathogenesis and Drug Screening"],"prefix":"10.1007","volume":"21","author":[{"given":"Jihong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilei","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-1660","authenticated-orcid":false,"given":"Dongrui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"10291","key":"10931_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0140-6736(21)00218-x","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson\u2019s disease. Lancet (London England), 397(10291), 2284\u20132303. https:\/\/doi.org\/10.1016\/s0140-6736(21)00218-x","journal-title":"Lancet (London England)"},{"issue":"5","key":"10931_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K. M., Holloway, R. G., Kieburtz, K., et al. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68(5), 384\u2013386. https:\/\/doi.org\/10.1212\/01.wnl.0000247740.47667.03","journal-title":"Neurology"},{"issue":"6","key":"10931_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning, G. K., Stankovic, I., Vignatelli, L., Fanciulli, A., Calandra-Buonaura, G., Seppi, K., et al. (2022). The movement disorder society criteria for the diagnosis of multiple system atrophy. Movement Disorders: Official Journal of the Movement Disorder Society, 37(6), 1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"8","key":"10931_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic, J., & Tan, E. K. (2020). Parkinson\u2019s disease: Etiopathogenesis and treatment. Journal of Neurology Neurosurgery and Psychiatry, 91(8), 795\u2013808. https:\/\/doi.org\/10.1136\/jnnp-2019-322338","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"5","key":"10931_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-024-01073-4","volume":"38","author":"E Menozzi","year":"2024","unstructured":"Menozzi, E., & Schapira, A. H. V. (2024). The gut microbiota in Parkinson disease: Interactions with drugs and potential for therapeutic applications. CNS Drugs, 38(5), 315\u2013331. https:\/\/doi.org\/10.1007\/s40263-024-01073-4","journal-title":"CNS Drugs"},{"issue":"1","key":"10931_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41398-024-02745-x","volume":"14","author":"S Yassine","year":"2024","unstructured":"Yassine, S., Almarouk, S., Gschwandtner, U., Auffret, M., Fuhr, P., Verin, M., et al. (2024). Electrophysiological signatures of anxiety in parkinson\u2019s disease. Translational Psychiatry, 14(1), 66. https:\/\/doi.org\/10.1038\/s41398-024-02745-x","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10931_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-024-00766-0","volume":"19","author":"MF Munoz-Pinto","year":"2024","unstructured":"Munoz-Pinto, M. F., Candeias, E., Melo-Marques, I., Esteves, A. R., Maranha, A., Magalh\u00e3es, J. D., et al. (2024). Gut-first parkinson\u2019s disease is encoded by gut dysbiome. Mol Neurodegener, 19(1), 78. https:\/\/doi.org\/10.1186\/s13024-024-00766-0","journal-title":"Mol Neurodegener"},{"issue":"5321","key":"10931_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with parkinson\u2019s disease. Science, 276(5321), 2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","journal-title":"Science"},{"issue":"2","key":"10931_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tins.2022.11.007","volume":"46","author":"M Sharma","year":"2023","unstructured":"Sharma, M., & Burr\u00e9, J. (2023). \u03b1-Synuclein in synaptic function and dysfunction. Trends in Neurosciences, 46(2), 153\u2013166. https:\/\/doi.org\/10.1016\/j.tins.2022.11.007","journal-title":"Trends in Neurosciences"},{"issue":"3","key":"10931_CR10","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi, P., Mechelli, A., Natale, G., Volpicelli-Daley, L., Di Lazzaro, G., & Ghiglieri, V. (2023). Alpha-synuclein in parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death & Disease, 14(3), 176. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10931_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tins.2024.01.002","volume":"47","author":"J Wang","year":"2024","unstructured":"Wang, J., Dai, L., Chen, S., Zhang, Z., Fang, X., & Zhang, Z. (2024). Protein-protein interactions regulating \u03b1-synuclein pathology. Trends in Neurosciences, 47(3), 209\u2013226. https:\/\/doi.org\/10.1016\/j.tins.2024.01.002","journal-title":"Trends in Neurosciences"},{"issue":"1","key":"10931_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12974-021-02079-1","volume":"18","author":"YN Zhang","year":"2021","unstructured":"Zhang, Y. N., Fan, J. K., Gu, L., Yang, H. M., Zhan, S. Q., & Zhang, H. (2021). Metabotropic glutamate receptor 5 inhibits \u03b1-synuclein-induced microglia inflammation to protect from neurotoxicity in parkinson\u2019s disease. Journal of Neuroinflammation, 18(1), 23. https:\/\/doi.org\/10.1186\/s12974-021-02079-1","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"10931_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41419-023-06251-8","volume":"14","author":"O Lurette","year":"2023","unstructured":"Lurette, O., Mart\u00edn-Jim\u00e9nez, R., Khan, M., Sheta, R., Jean, S., Schofield, M., et al. (2023). Aggregation of alpha-synuclein disrupts mitochondrial metabolism and induce mitophagy via Cardiolipin externalization. Cell Death & Disease, 14(11), 729. https:\/\/doi.org\/10.1038\/s41419-023-06251-8","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10931_CR14","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-024-03268-4","volume":"21","author":"CS Pei","year":"2024","unstructured":"Pei, C. S., Hou, X. O., Ma, Z. Y., Tu, H. Y., Qian, H. C., Li, Y., et al. (2024). \u03b1-Synuclein disrupts microglial autophagy through STAT1-dependent suppression of Ulk1 transcription. Journal of Neuroinflammation, 21(1), 275. https:\/\/doi.org\/10.1186\/s12974-024-03268-4","journal-title":"Journal of Neuroinflammation"},{"issue":"12","key":"10931_CR15","doi-asserted-by":"publisher","first-page":"e13522","DOI":"10.1111\/acel.13522","volume":"20","author":"HY Tu","year":"2021","unstructured":"Tu, H. Y., Yuan, B. S., Hou, X. O., Zhang, X. J., Pei, C. S., Ma, Y. T., et al. (2021). \u03b1-synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of parkinson\u2019s disease. Aging Cell, 20(12), e13522. https:\/\/doi.org\/10.1111\/acel.13522","journal-title":"Aging Cell"},{"issue":"s2","key":"10931_CR16","doi-asserted-by":"publisher","first-page":"S333","DOI":"10.3233\/jpd-240007","volume":"14","author":"A Pilotto","year":"2024","unstructured":"Pilotto, A., Zanusso, G., Antelmi, E., Okuzumi, A., Zatti, C., Lupini, A., et al. (2024). Biofluid markers and tissue biopsies analyses for the prodromal and earliest phase of parkinson\u2019s disease. Journal of Parkinson\u2019s Disease, 14(s2), S333\u2013s344. https:\/\/doi.org\/10.3233\/jpd-240007","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"3","key":"10931_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H., Chong, C. W., Lim, S. Y., Yap, I. K. S., Teh, C. S. J., Loke, M. F., et al. (2021). Gut microbial ecosystem in Parkinson disease: New clinicobiological insights from Multi-Omics. Annals of Neurology, 89(3), 546\u2013559. https:\/\/doi.org\/10.1002\/ana.25982","journal-title":"Annals of Neurology"},{"issue":"1","key":"10931_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mds.29620","volume":"39","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Stewart, T., Zhang, C., Wang, P., Xu, Z., Jin, J., et al. (2024). Erythrocytic \u03b1-Synuclein and the gut microbiome: Kindling of the gut-Brain Axis in parkinson\u2019s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 39(1), 40\u201352. https:\/\/doi.org\/10.1002\/mds.29620","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10931_CR19","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1038\/s41467-023-43224-z","volume":"14","author":"RL McFleder","year":"2023","unstructured":"McFleder, R. L., Makhotkina, A., Groh, J., Keber, U., Imdahl, F., Pe\u00f1a Mosca, J., et al. (2023). Brain-to-gut trafficking of alpha-synuclein by CD11c(+) cells in a mouse model of parkinson\u2019s disease. Nature Communications, 14(1), 7529. https:\/\/doi.org\/10.1038\/s41467-023-43224-z","journal-title":"Nature Communications"},{"issue":"8","key":"10931_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988). Reactive microglia are positive for HLA-DR in the substantia Nigra of parkinson\u2019s and alzheimer\u2019s disease brains. Neurology, 38(8), 1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"issue":"1","key":"10931_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41531-022-00394-9","volume":"8","author":"T Jiang","year":"2022","unstructured":"Jiang, T., Xu, C., Gao, S., Zhang, J., Zheng, J., Wu, X., et al. (2022). Cathepsin L-containing exosomes from \u03b1-synuclein-activated microglia induce neurotoxicity through the P2X7 receptor. NPJ Parkinson\u2019s Disease, 8(1), 127. https:\/\/doi.org\/10.1038\/s41531-022-00394-9","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"1","key":"10931_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.stem.2018.06.015","volume":"23","author":"A Sommer","year":"2018","unstructured":"Sommer, A., Marxreiter, F., Krach, F., Fadler, T., Grosch, J., Maroni, M., et al. (2018). Th17 lymphocytes induce neuronal cell death in a human iPSC-Based model of parkinson\u2019s disease. Cell Stem Cell, 23(1), 123\u2013131e126. https:\/\/doi.org\/10.1016\/j.stem.2018.06.015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10931_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022). The role of Toll-like receptors and neuroinflammation in parkinson\u2019s disease. Journal of Neuroinflammation, 19(1), 135. https:\/\/doi.org\/10.1186\/s12974-022-02496-w","journal-title":"Journal of Neuroinflammation"},{"issue":"8","key":"10931_CR24","doi-asserted-by":"publisher","first-page":"e70003","DOI":"10.1111\/cns.70003","volume":"30","author":"H Yang","year":"2024","unstructured":"Yang, H., Shao, Y., Hu, Y., Qian, J., Wang, P., Tian, L., et al. (2024). Fecal microbiota from patients with parkinson\u2019s disease intensifies inflammation and neurodegeneration in A53T mice. CNS Neuroscience & Therapeutics, 30(8), e70003. https:\/\/doi.org\/10.1111\/cns.70003","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10931_CR25","doi-asserted-by":"publisher","unstructured":"Brash-Arias, D., Garc\u00eda, L. I., P\u00e9rez-Estudillo, C. A., Rojas-Dur\u00e1n, F., Aranda-Abreu, G. E., Herrera-Covarrubias, D. (2024). The Role of Astrocytes and Alpha-Synuclein in Parkinson\u2019s Disease: A Review. NeuroSci,\u00a05(1),71\u201386. https:\/\/doi.org\/10.3390\/neurosci5010005","DOI":"10.3390\/neurosci5010005"},{"issue":"3","key":"10931_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tins.2020.01.003","volume":"43","author":"ID Vainchtein","year":"2020","unstructured":"Vainchtein, I. D., & Molofsky, A. V. (2020). Astrocytes and microglia: In sickness and in health. Trends in Neurosciences, 43(3), 144\u2013154. https:\/\/doi.org\/10.1016\/j.tins.2020.01.003","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10931_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41419-023-05807-y","volume":"14","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Ding, L., Chen, H., Zhang, M., Ma, R., Zheng, S., et al. (2023). Cntnap4 partial deficiency exacerbates \u03b1-synuclein pathology through astrocyte-microglia C3-C3aR pathway. Cell Death & Disease, 14(4), 285. https:\/\/doi.org\/10.1038\/s41419-023-05807-y","journal-title":"Cell Death & Disease"},{"key":"10931_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos, D., Lebouvier, T., Lardeux, B., Biraud, M., Rouaud, T., Pouclet, H., et al. (2013). Colonic inflammation in parkinson\u2019s disease. Neurobiology of Diseases, 50, 42\u201348. https:\/\/doi.org\/10.1016\/j.nbd.2012.09.007","journal-title":"Neurobiology of Diseases"},{"issue":"3","key":"10931_CR29","doi-asserted-by":"publisher","first-page":"e14670","DOI":"10.1111\/cns.14670","volume":"30","author":"Y Lu","year":"2024","unstructured":"Lu, Y., Dong, W., Xue, X., Sun, J., Yan, J., Wei, X., et al. (2024). The severity assessment of parkinson\u2019s disease based on plasma inflammatory factors and third ventricle width by transcranial sonography. CNS Neuroscience & Therapeutics, 30(3), e14670. https:\/\/doi.org\/10.1111\/cns.14670","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"5","key":"10931_CR30","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1021\/acschemneuro.8b00733","volume":"10","author":"D Bhattacharyya","year":"2019","unstructured":"Bhattacharyya, D., Mohite, G. M., Krishnamoorthy, J., Gayen, N., Mehra, S., Navalkar, A., et al. (2019). Lipopolysaccharide from gut microbiota modulates \u03b1-Synuclein aggregation and alters its biological function. ACS Chemical Neuroscience, 10(5), 2229\u20132236. https:\/\/doi.org\/10.1021\/acschemneuro.8b00733","journal-title":"ACS Chemical Neuroscience"},{"issue":"1","key":"10931_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41522-021-00242-3","volume":"7","author":"Y Yan","year":"2021","unstructured":"Yan, Y., Ren, S., Duan, Y., Lu, C., Niu, Y., Wang, Z., et al. (2021). Gut microbiota and metabolites of \u03b1-synuclein Transgenic monkey models with early stage of parkinson\u2019s disease. NPJ Biofilms and Microbiomes, 7(1), 69. https:\/\/doi.org\/10.1038\/s41522-021-00242-3","journal-title":"NPJ Biofilms and Microbiomes"},{"issue":"1","key":"10931_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z., Ning, J., Bao, X. Q., Shang, M., Ma, J., Li, G., et al. (2021). Fecal microbiota transplantation protects rotenone-induced parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome, 9(1), 226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9","journal-title":"Microbiome"},{"issue":"6","key":"10931_CR33","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1039\/d3fo05169b","volume":"15","author":"QX Gan","year":"2024","unstructured":"Gan, Q. X., Peng, M. Y., Wei, H. B., Chen, L. L., Chen, X. Y., Li, Z. H., et al. (2024). Gastrodia Elata polysaccharide alleviates parkinson\u2019s disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota. Food & Function, 15(6), 2920\u20132938. https:\/\/doi.org\/10.1039\/d3fo05169b","journal-title":"Food & Function"},{"key":"10931_CR34","doi-asserted-by":"publisher","unstructured":"Meng, T., Zhang, Y., Huang, J., Pandey, V., Fu, S., & Ma, S. (2024). Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson\u2019s disease, and alters gut microbiota and metabolite composition. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 124, 155309. https:\/\/doi.org\/10.1016\/j.phymed.2023.155309","DOI":"10.1016\/j.phymed.2023.155309"},{"key":"10931_CR35","doi-asserted-by":"publisher","unstructured":"Claudino Dos Santos, J. C., Lima, M. P. P., Brito, G. A. C., & Viana, G. S. B. (2023). Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis. Ageing Research Reviews, 84,\u00a0 101812. https:\/\/doi.org\/10.1016\/j.arr.2022.101812","DOI":"10.1016\/j.arr.2022.101812"},{"issue":"1","key":"10931_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich, M. T., Oertel, W. H., Surmeier, D. J., & Geibl, F. F. (2023). Mitochondrial dysfunction in parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol Neurodegener, 18(1), 83. https:\/\/doi.org\/10.1186\/s13024-023-00676-7","journal-title":"Mol Neurodegener"},{"issue":"12","key":"10931_CR37","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/j.neuron.2022.03.015","volume":"110","author":"XT Cheng","year":"2022","unstructured":"Cheng, X. T., Huang, N., & Sheng, Z. H. (2022). Programming axonal mitochondrial maintenance and bioenergetics in neurodegeneration and regeneration. Neuron, 110(12), 1899\u20131923. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.015","journal-title":"Neuron"},{"issue":"4587","key":"10931_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"JW Langston","year":"1983","unstructured":"Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983). Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science, 219(4587), 979\u2013980. https:\/\/doi.org\/10.1126\/science.6823561","journal-title":"Science"},{"key":"10931_CR39","doi-asserted-by":"publisher","unstructured":"Li, H., Zhang, J., Shen, Y., Ye, Y., Jiang, Q., Chen, L. (2024). Targeting Mitochondrial Complex I Deficiency in MPP(+)\/MPTP-induced Parkinson\u2019s Disease Cell Culture and Mouse Models by Transducing Yeast NDI1 Gene. Biological Procedures Online,\u00a026(1), 9. https:\/\/doi.org\/10.1186\/s12575-024-00236-3","DOI":"10.1186\/s12575-024-00236-3"},{"issue":"7886","key":"10931_CR40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","volume":"599","author":"P Gonz\u00e1lez-Rodr\u00edguez","year":"2021","unstructured":"Gonz\u00e1lez-Rodr\u00edguez, P., Zampese, E., Stout, K. A., Guzman, J. N., Ilijic, E., Yang, B., et al. (2021). Disruption of mitochondrial complex I induces progressive parkinsonism. Nature, 599(7886), 650\u2013656. https:\/\/doi.org\/10.1038\/s41586-021-04059-0","journal-title":"Nature"},{"key":"10931_CR41","doi-asserted-by":"publisher","unstructured":"Dion\u00edsio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021). Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Research Reviews, 67, 101263. https:\/\/doi.org\/10.1016\/j.arr.2021.101263","DOI":"10.1016\/j.arr.2021.101263"},{"issue":"6","key":"10931_CR42","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.freeradbiomed.2004.05.034","volume":"37","author":"MD Brand","year":"2004","unstructured":"Brand, M. D., Affourtit, C., Esteves, T. C., Green, K., Lambert, A. J., Miwa, S., et al. (2004). Mitochondrial superoxide: Production, biological effects, and activation of uncoupling proteins. Free Radical Biology & Medicine, 37(6), 755\u2013767. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2004.05.034","journal-title":"Free Radical Biology & Medicine"},{"key":"10931_CR43","doi-asserted-by":"publisher","unstructured":"Ding, X. S., Gao, L., Han, Z., Eleuteri, S., Shi, W., Shen, Y. (2023). Ferroptosis in Parkinson\u2019s disease: Molecular mechanisms and therapeutic potential. Ageing Research Reviews, 91, 102077. https:\/\/doi.org\/10.1016\/j.arr.2023.102077","DOI":"10.1016\/j.arr.2023.102077"},{"issue":"4","key":"10931_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41419-024-06617-6","volume":"15","author":"S Barnhoorn","year":"2024","unstructured":"Barnhoorn, S., Milanese, C., Li, T., Dons, L., Ghazvini, M., Sette, M., et al. (2024). Orthogonal analysis of mitochondrial function in parkinson\u2019s disease patients. Cell Death & Disease, 15(4), 243. https:\/\/doi.org\/10.1038\/s41419-024-06617-6","journal-title":"Cell Death & Disease"},{"key":"10931_CR45","doi-asserted-by":"publisher","unstructured":"Nechushtai, L., Frenkel, D., & Pinkas-Kramarski, R. (2023). Autophagy in Parkinson\u2019s Disease. Biomolecules, 13(10). https:\/\/doi.org\/10.3390\/biom13101435","DOI":"10.3390\/biom13101435"},{"issue":"4","key":"10931_CR46","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida, A. B., Williamson, M., Narendra, D. P., Wade-Martins, R., & Ryan, B. J. (2021). Mitochondrial dysfunction and mitophagy in parkinson\u2019s disease: From mechanism to therapy. Trends in Biochemical Sciences, 46(4), 329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends in Biochemical Sciences"},{"key":"10931_CR47","doi-asserted-by":"publisher","unstructured":"Singh, F., Prescott, A. R., Rosewell, P., Ball, G., Reith, A. D., & Ganley, I. G. (2021). Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice. eLife. 10. https:\/\/doi.org\/10.7554\/eLife.67604","DOI":"10.7554\/eLife.67604"},{"issue":"5","key":"10931_CR48","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"key":"10931_CR49","doi-asserted-by":"publisher","unstructured":"Cesar, A. S., Matthias, S., George, J. M., Konrad, H., Darrell, N. K., & Gustavo, M. (2008). Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells, 27(3). https:\/\/doi.org\/10.1634\/stemcells.2008-1075","DOI":"10.1634\/stemcells.2008-1075"},{"key":"10931_CR50","doi-asserted-by":"publisher","unstructured":"Hiroshi, B., Naoki, N., Noemi, F., Toshiaki, T., Koichi, S., Masayuki, S., et al. (2011). Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors. Proc Natl Acad Sci USA, 108(34). https:\/\/doi.org\/10.1073\/pnas.1103509108","DOI":"10.1073\/pnas.1103509108"},{"issue":"7","key":"10931_CR51","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/mds.29434","volume":"38","author":"J Pu","year":"2023","unstructured":"Pu, J., Lin, L., Jiang, H., Hu, Z., Li, H., Yan, Z., et al. (2023). Parkin maintains robust pacemaking in human induced pluripotent stem Cell-Derived A9 dopaminergic neurons. Movement Disorders: Official Journal of the Movement Disorder Society, 38(7), 1273\u20131281. https:\/\/doi.org\/10.1002\/mds.29434","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"key":"10931_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","volume":"44","author":"GE V\u00e1zquez-V\u00e9lez","year":"2021","unstructured":"V\u00e1zquez-V\u00e9lez, G. E., & Zoghbi, H. Y. (2021). Parkinson\u2019s disease genetics and pathophysiology. Annual Review of Neuroscience, 44, 87\u2013108. https:\/\/doi.org\/10.1146\/annurev-neuro-100720-034518","journal-title":"Annual Review of Neuroscience"},{"key":"10931_CR53","doi-asserted-by":"publisher","unstructured":"Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J. (2017). Parkinson disease. Nature Reviews Disease Primers,\u00a03, 17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","DOI":"10.1038\/nrdp.2017.13"},{"issue":"12","key":"10931_CR54","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrd3577","volume":"10","author":"M Grskovic","year":"2011","unstructured":"Grskovic, M., Javaherian, A., Strulovici, B., & Daley, G. Q. (2011). Induced pluripotent stem cells\u2013opportunities for disease modelling and drug discovery. Nature Reviews. Drug Discovery, 10(12), 915\u2013929. https:\/\/doi.org\/10.1038\/nrd3577","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"6645","key":"10931_CR55","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). Alpha-synuclein in lewy bodies. Nature, 388(6645), 839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"10931_CR56","doi-asserted-by":"publisher","unstructured":"Polymeropoulos, M., Lavedan, C., Leroy, E., Ide, S., Dehejia, A., Dutra, A. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science (New York, NY), 276(5321), 2045\u20132047. https:\/\/doi.org\/10.1126\/science.276.5321.2045","DOI":"10.1126\/science.276.5321.2045"},{"issue":"5646","key":"10931_CR57","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"A Singleton","year":"2003","unstructured":"Singleton, A., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., et al. (2003). alpha-Synuclein locus triplication causes parkinson\u2019s disease. Science (New York NY), 302(5646), 841. https:\/\/doi.org\/10.1126\/science.1090278","journal-title":"Science (New York NY)"},{"issue":"9440","key":"10931_CR58","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/s0140-6736(04)17104-3","volume":"364","author":"P Ib\u00e1\u00f1ez","year":"2004","unstructured":"Ib\u00e1\u00f1ez, P., Bonnet, A. M., D\u00e9barges, B., Lohmann, E., Tison, F., Pollak, P., et al. (2004). Causal relation between alpha-synuclein gene duplication and Familial parkinson\u2019s disease. Lancet (London England), 364(9440), 1169\u20131171. https:\/\/doi.org\/10.1016\/s0140-6736(04)17104-3","journal-title":"Lancet (London England)"},{"issue":"7","key":"10931_CR59","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H., Lewis, A. J., Genoud, C., Hench, J., Moors, T. E., Navarro, P. P., et al. (2019). Lewy pathology in parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nature Neuroscience, 22(7), 1099\u20131109. https:\/\/doi.org\/10.1038\/s41593-019-0423-2","journal-title":"Nature Neuroscience"},{"issue":"4","key":"10931_CR60","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/15548627.2020.1739441","volume":"17","author":"P Stathakos","year":"2021","unstructured":"Stathakos, P., Jim\u00e9nez-Moreno, N., Crompton, L. A., Nistor, P. A., Badger, J. L., Barbuti, P. A., et al. (2021). A monolayer HiPSC culture system for autophagy\/mitophagy studies in human dopaminergic neurons. Autophagy, 17(4), 855\u2013871. https:\/\/doi.org\/10.1080\/15548627.2020.1739441","journal-title":"Autophagy"},{"issue":"10","key":"10931_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41419-022-05330-6","volume":"13","author":"A Iannielli","year":"2022","unstructured":"Iannielli, A., Luoni, M., Giannelli, S. G., Ferese, R., Ordazzo, G., Fossati, M., et al. (2022). Modeling native and seeded synuclein aggregation and related cellular dysfunctions in dopaminergic neurons derived by a new set of isogenic iPSC lines with SNCA multiplications. Cell Death & Disease, 13(10), 881. https:\/\/doi.org\/10.1038\/s41419-022-05330-6","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10931_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41531-024-00696-0","volume":"10","author":"I Kinnart","year":"2024","unstructured":"Kinnart, I., Manders, L., Heyninck, T., Imberechts, D., Praschberger, R., Schoovaerts, N., et al. (2024). Elevated \u03b1-synuclein levels inhibit mitophagic flux. NPJ Parkinson\u2019s Disease, 10(1), 80. https:\/\/doi.org\/10.1038\/s41531-024-00696-0","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"5","key":"10931_CR63","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/15548627.2022.2045534","volume":"18","author":"S Prieto Huarcaya","year":"2022","unstructured":"Prieto Huarcaya, S., Drobny, A., Marques, A. R. A., Di Spiezio, A., Dobert, J. P., Balta, D., et al. (2022). Recombinant pro-CTSD (cathepsin D) enhances SNCA\/\u03b1-Synuclein degradation in \u03b1-Synucleinopathy models. Autophagy, 18(5), 1127\u20131151. https:\/\/doi.org\/10.1080\/15548627.2022.2045534","journal-title":"Autophagy"},{"issue":"3","key":"10931_CR64","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","volume":"45","author":"EM Rocha","year":"2022","unstructured":"Rocha, E. M., Keeney, M. T., Di Maio, R., De Miranda, B. R., & Greenamyre, J. T. (2022). LRRK2 and idiopathic parkinson\u2019s disease. Trends in Neurosciences, 45(3), 224\u2013236. https:\/\/doi.org\/10.1016\/j.tins.2021.12.002","journal-title":"Trends in Neurosciences"},{"issue":"4","key":"10931_CR65","doi-asserted-by":"publisher","first-page":"e0175424","DOI":"10.1371\/journal.pone.0175424","volume":"12","author":"M Artzi","year":"2017","unstructured":"Artzi, M., Even-Sapir, E., Lerman Shacham, H., Thaler, A., Urterger, A. O., Bressman, S., et al. (2017). DaT-SPECT assessment depicts dopamine depletion among asymptomatic G2019S LRRK2 mutation carriers. PloS One, 12(4), e0175424. https:\/\/doi.org\/10.1371\/journal.pone.0175424","journal-title":"PloS One"},{"issue":"9457","key":"10931_CR66","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s0140-6736(05)17828-3","volume":"365","author":"WC Nichols","year":"2005","unstructured":"Nichols, W. C., Pankratz, N., Hernandez, D., Pais\u00e1n-Ru\u00edz, C., Jain, S., Halter, C. A., et al. (2005). Genetic screening for a single common LRRK2 mutation in Familial parkinson\u2019s disease. Lancet (London England), 365(9457), 410\u2013412. https:\/\/doi.org\/10.1016\/s0140-6736(05)17828-3","journal-title":"Lancet (London England)"},{"issue":"13","key":"10931_CR67","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1016\/j.cell.2021.05.004","volume":"184","author":"A Myasnikov","year":"2021","unstructured":"Myasnikov, A., Zhu, H., Hixson, P., Xie, B., Yu, K., Pitre, A., et al. (2021). Structural analysis of the full-length human LRRK2. Cell, 184(13), 3519\u20133527e3510. https:\/\/doi.org\/10.1016\/j.cell.2021.05.004","journal-title":"Cell"},{"issue":"1","key":"10931_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-biochem-030122-051144","volume":"93","author":"DR Alessi","year":"2024","unstructured":"Alessi, D. R., & Pfeffer, S. R. (2024). Leucine-Rich repeat kinases. Annual Review of Biochemistry, 93(1), 261\u2013287. https:\/\/doi.org\/10.1146\/annurev-biochem-030122-051144","journal-title":"Annual Review of Biochemistry"},{"issue":"5","key":"10931_CR69","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s, A., Richaud-Patin, Y., Carballo-Carbajal, I., Jim\u00e9nez-Delgado, S., Caig, C., Mora, S., et al. (2012). Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic parkinson\u2019s disease. EMBO Molecular Medicine, 4(5), 380\u2013395. https:\/\/doi.org\/10.1002\/emmm.201200215","journal-title":"EMBO Molecular Medicine"},{"issue":"10","key":"10931_CR70","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.cub.2021.02.061","volume":"31","author":"CA Boecker","year":"2021","unstructured":"Boecker, C. A., Goldsmith, J., Dou, D., Cajka, G. G., & Holzbaur, E. L. F. (2021). Increased LRRK2 kinase activity alters neuronal autophagy by disrupting the axonal transport of autophagosomes. Current Biology: CB, 31(10), 2140\u20132154e2146. https:\/\/doi.org\/10.1016\/j.cub.2021.02.061","journal-title":"Current Biology: CB"},{"issue":"12","key":"10931_CR71","doi-asserted-by":"publisher","first-page":"e3001480","DOI":"10.1371\/journal.pbio.3001480","volume":"19","author":"A Mamais","year":"2021","unstructured":"Mamais, A., Kluss, J. H., Bonet-Ponce, L., Landeck, N., Langston, R. G., Smith, N., et al. (2021). Mutations in LRRK2 linked to Parkinson disease sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia. PLoS Biology, 19(12), e3001480. https:\/\/doi.org\/10.1371\/journal.pbio.3001480","journal-title":"PLoS Biology"},{"key":"10931_CR72","doi-asserted-by":"publisher","unstructured":"Yao, L., Lu, F., Koc, S., Zheng, Z., Wang, B., Zhang, S. (2023). LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1\/TGF-\u03b21 in Parkinson\u2019s Disease. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10(30), e2303711. https:\/\/doi.org\/10.1002\/advs.202303711","DOI":"10.1002\/advs.202303711"},{"issue":"4","key":"10931_CR73","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.stem.2020.08.002","volume":"27","author":"JW Kim","year":"2020","unstructured":"Kim, J. W., Yin, X., Jhaldiyal, A., Khan, M. R., Martin, I., Xie, Z., et al. (2020). Defects in mRNA translation in LRRK2-Mutant hiPSC-Derived dopaminergic neurons lead to dysregulated calcium homeostasis. Cell Stem Cell, 27(4), 633\u2013645e637. https:\/\/doi.org\/10.1016\/j.stem.2020.08.002","journal-title":"Cell Stem Cell"},{"key":"10931_CR74","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1146\/annurev-pathol-012513-104649","volume":"10","author":"SA Oakes","year":"2015","unstructured":"Oakes, S. A., & Papa, F. R. (2015). The role of Endoplasmic reticulum stress in human pathology. Annual Review of Pathology, 10, 173\u2013194. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104649","journal-title":"Annual Review of Pathology"},{"issue":"1","key":"10931_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40478-019-0716-4","volume":"7","author":"JH Lee","year":"2019","unstructured":"Lee, J. H., Han, J. H., Kim, H., Park, S. M., Joe, E. H., & Jou, I. (2019). Parkinson\u2019s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes. Acta Neuropathologica Communications, 7(1), 68. https:\/\/doi.org\/10.1186\/s40478-019-0716-4","journal-title":"Acta Neuropathologica Communications"},{"key":"10931_CR76","doi-asserted-by":"publisher","unstructured":"Migdalska-Richards, A., & Schapira, A. (2016). The relationship between glucocerebrosidase mutations and Parkinson disease. Journal of Neurochemistry, 77\u201390. https:\/\/doi.org\/10.1111\/jnc.13385","DOI":"10.1111\/jnc.13385"},{"issue":"6","key":"10931_CR77","doi-asserted-by":"publisher","first-page":"eabm6393","DOI":"10.1126\/sciadv.abm6393","volume":"8","author":"SH Kuo","year":"2022","unstructured":"Kuo, S. H., Tasset, I., Cheng, M. M., Diaz, A., Pan, M. K., Lieberman, O. J., et al. (2022). Mutant glucocerebrosidase impairs \u03b1-synuclein degradation by Blockade of chaperone-mediated autophagy. Science Advances, 8(6), eabm6393. https:\/\/doi.org\/10.1126\/sciadv.abm6393","journal-title":"Science Advances"},{"issue":"1","key":"10931_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-019-0336-2","volume":"14","author":"J Do","year":"2019","unstructured":"Do, J., McKinney, C., Sharma, P., & Sidransky, E. (2019). Glucocerebrosidase and its relevance to Parkinson disease. Mol Neurodegener, 14(1), 36. https:\/\/doi.org\/10.1186\/s13024-019-0336-2","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10931_CR79","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-023-00616-8","volume":"9","author":"I Rosety","year":"2023","unstructured":"Rosety, I., Zagare, A., Saraiva, C., Nickels, S., Antony, P., Almeida, C., et al. (2023). Impaired neuron differentiation in GBA-associated parkinson\u2019s disease is linked to cell cycle defects in organoids. NPJ Parkinson\u2019s Disease, 9(1), 166. https:\/\/doi.org\/10.1038\/s41531-023-00616-8","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"3","key":"10931_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","volume":"6","author":"H Fernandes","year":"2016","unstructured":"Fernandes, H., Hartfield, E., Christian, H., Emmanoulidou, E., Zheng, Y., Booth, H., et al. (2016). ER stress and autophagic perturbations lead to elevated extracellular \u03b1-Synuclein in GBA-N370S parkinson\u2019s iPSC-Derived dopamine neurons. Stem Cell Reports, 6(3), 342\u2013356. https:\/\/doi.org\/10.1016\/j.stemcr.2016.01.013","journal-title":"Stem Cell Reports"},{"issue":"3","key":"10931_CR81","doi-asserted-by":"publisher","first-page":"112180","DOI":"10.1016\/j.celrep.2023.112180","volume":"42","author":"H Bogetofte","year":"2023","unstructured":"Bogetofte, H., Ryan, B. J., Jensen, P., Schmidt, S. I., Vergoossen, D. L. E., Barnkob, M. B., et al. (2023). Post-translational proteomics platform identifies neurite outgrowth impairments in parkinson\u2019s disease GBA-N370S dopamine neurons. Cell Rep, 42(3), 112180. https:\/\/doi.org\/10.1016\/j.celrep.2023.112180","journal-title":"Cell Rep"},{"issue":"1","key":"10931_CR82","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-024-00694-2","volume":"10","author":"QB Do","year":"2024","unstructured":"Do, Q. B., Noor, H., Marquez-Gomez, R., Cramb, K. M. L., Ng, B., Abbey, A., et al. (2024). Early deficits in an in vitro striatal microcircuit model carrying the parkinson\u2019s GBA-N370S mutation. NPJ Parkinson\u2019s Disease, 10(1), 82. https:\/\/doi.org\/10.1038\/s41531-024-00694-2","journal-title":"NPJ Parkinson\u2019s Disease"},{"issue":"21","key":"10931_CR83","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/nejm200005253422103","volume":"342","author":"C L\u00fccking","year":"2000","unstructured":"L\u00fccking, C., D\u00fcrr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., et al. (2000). Association between early-onset parkinson\u2019s disease and mutations in the parkin gene. The New England Journal of Medicine, 342(21), 1560\u20131567. https:\/\/doi.org\/10.1056\/nejm200005253422103","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10931_CR84","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1093\/brain\/awac313","volume":"145","author":"D Imberechts","year":"2022","unstructured":"Imberechts, D., Kinnart, I., Wauters, F., Terbeek, J., Manders, L., Wierda, K., et al. (2022). DJ-1 is an essential downstream mediator in PINK1\/parkin-dependent mitophagy. Brain: A Journal of Neurology, 145(12), 4368\u20134384. https:\/\/doi.org\/10.1093\/brain\/awac313","journal-title":"Brain: A Journal of Neurology"},{"issue":"2","key":"10931_CR85","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","volume":"85","author":"A Pickrell","year":"2015","unstructured":"Pickrell, A., & Youle, R. (2015). The roles of PINK1, parkin, and mitochondrial fidelity in parkinson\u2019s disease. Neuron, 85(2), 257\u2013273. https:\/\/doi.org\/10.1016\/j.neuron.2014.12.007","journal-title":"Neuron"},{"issue":"8","key":"10931_CR86","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.celrep.2017.10.068","volume":"21","author":"C Oh","year":"2017","unstructured":"Oh, C., Sultan, A., Platzer, J., Dolatabadi, N., Soldner, F., McClatchy, D., et al. (2017). S-Nitrosylation of PINK1 attenuates PINK1\/Parkin-Dependent mitophagy in hiPSC-Based parkinson\u2019s disease models. Cell Reports, 21(8), 2171\u20132182. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.068","journal-title":"Cell Reports"},{"issue":"29","key":"10931_CR87","doi-asserted-by":"publisher","first-page":"eadh3347","DOI":"10.1126\/sciadv.adh3347","volume":"9","author":"W Peng","year":"2023","unstructured":"Peng, W., Schr\u00f6der, L., Song, P., Wong, Y., & Krainc, D. (2023). Parkin regulates amino acid homeostasis at mitochondria-lysosome (M\/L) contact sites in parkinson\u2019s disease. Science Advances, 9(29), eadh3347. https:\/\/doi.org\/10.1126\/sciadv.adh3347","journal-title":"Science Advances"},{"issue":"7","key":"10931_CR88","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/mds.29025","volume":"37","author":"K Wasner","year":"2022","unstructured":"Wasner, K., Smajic, S., Ghelfi, J., Delcambre, S., Prada-Medina, C., Knappe, E., et al. (2022). Parkin deficiency impairs mitochondrial DNA dynamics and propagates inflammation. Movement Disorders: Official Journal of the Movement Disorder Society, 37(7), 1405\u20131415. https:\/\/doi.org\/10.1002\/mds.29025","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"10","key":"10931_CR89","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1038\/s41380-022-01663-y","volume":"27","author":"J Krauskopf","year":"2022","unstructured":"Krauskopf, J., Eggermont, K., Madeiro Da Costa, R. F., Bohler, S., Hauser, D., Caiment, F., et al. (2022). Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic parkinson\u2019s disease. Molecular Psychiatry, 27(10), 4355\u20134367. https:\/\/doi.org\/10.1038\/s41380-022-01663-y","journal-title":"Molecular Psychiatry"},{"key":"10931_CR90","doi-asserted-by":"publisher","unstructured":"MacMahon Copas, A., McComish, S., Fletcher, J., & Caldwell, M. (2021). The Pathogenesis of Parkinson\u2019s Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes? Frontiers in Neurology,\u00a012, 666737. https:\/\/doi.org\/10.3389\/fneur.2021.666737","DOI":"10.3389\/fneur.2021.666737"},{"key":"10931_CR91","doi-asserted-by":"publisher","unstructured":"Kam, T., Hinkle, J., Dawson, T., & Dawson, V. (2020). Microglia and astrocyte dysfunction in parkinson\u2019s disease. Neurobiology of Disease, 144,\u00a0105028. https:\/\/doi.org\/10.1016\/j.nbd.2020.105028","DOI":"10.1016\/j.nbd.2020.105028"},{"issue":"6","key":"10931_CR92","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"H Booth","year":"2017","unstructured":"Booth, H., Hirst, W., & Wade-Martins, R. (2017). The role of astrocyte dysfunction in parkinson\u2019s disease pathogenesis. Trends in Neurosciences, 40(6), 358\u2013370. https:\/\/doi.org\/10.1016\/j.tins.2017.04.001","journal-title":"Trends in Neurosciences"},{"key":"10931_CR93","doi-asserted-by":"publisher","unstructured":"Angelique dD, Giulia, C., Carles, C., Meritxell, P-E., Juan Pablo, M., Yvonne, R-P, et al. (2019). Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson\u2019s Disease. Stem Cell Reports, 12(2). https:\/\/doi.org\/10.1016\/j.stemcr.2018.12.011","DOI":"10.1016\/j.stemcr.2018.12.011"},{"issue":"1","key":"10931_CR94","doi-asserted-by":"publisher","first-page":"9003","DOI":"10.1038\/s41598-017-09362-3","volume":"7","author":"W Haenseler","year":"2017","unstructured":"Haenseler, W., Zambon, F., Lee, H., Vowles, J., Rinaldi, F., Duggal, G., et al. (2017). Excess \u03b1-synuclein compromises phagocytosis in iPSC-derived macrophages. Scientific Reports, 7(1), 9003. https:\/\/doi.org\/10.1038\/s41598-017-09362-3","journal-title":"Scientific Reports"},{"issue":"1","key":"10931_CR95","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1038\/s41467-023-38215-z","volume":"14","author":"KC Paul","year":"2023","unstructured":"Paul, K. C., Krolewski, R. C., Lucumi Moreno, E., Blank, J., Holton, K. M., Ahfeldt, T., et al. (2023). A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides. Nature Communications, 14(1), 2803. https:\/\/doi.org\/10.1038\/s41467-023-38215-z","journal-title":"Nature Communications"},{"issue":"12","key":"10931_CR96","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/s41593-024-01775-4","volume":"27","author":"A Bayati","year":"2024","unstructured":"Bayati, A., Ayoubi, R., Aguila, A., Zorca, C. E., Deyab, G., Han, C., et al. (2024). Modeling parkinson\u2019s disease pathology in human dopaminergic neurons by sequential exposure to \u03b1-synuclein fibrils and Proinflammatory cytokines. Nature Neuroscience, 27(12), 2401\u20132416. https:\/\/doi.org\/10.1038\/s41593-024-01775-4","journal-title":"Nature Neuroscience"},{"key":"10931_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.11.003","volume":"125","author":"A Hopkins","year":"2015","unstructured":"Hopkins, A., DeSimone, E., Chwalek, K., & Kaplan, D. (2015). 3D in vitro modeling of the central nervous system. Progress in Neurobiology, 125, 1\u201325. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.11.003","journal-title":"Progress in Neurobiology"},{"key":"10931_CR98","doi-asserted-by":"publisher","unstructured":"Becerra-Calixto, A., Mukherjee, A., Ramirez, S., Sepulveda, S., Sinha, T., Al-Lahham, R., et al. (2023). Lewy Body-like Pathology and Loss of Dopaminergic Neurons in Midbrain Organoids Derived from Familial Parkinson\u2019s Disease Patient. Cells, 12(4). https:\/\/doi.org\/10.3390\/cells12040625","DOI":"10.3390\/cells12040625"},{"issue":"8","key":"10931_CR99","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.stemcr.2021.06.006","volume":"16","author":"P Valiulahi","year":"2021","unstructured":"Valiulahi, P., Vidyawan, V., Puspita, L., Oh, Y., Juwono, V., Sittipo, P., et al. (2021). Generation of caudal-type serotonin neurons and hindbrain-fate organoids from hPSCs. Stem Cell Reports, 16(8), 1938\u20131952. https:\/\/doi.org\/10.1016\/j.stemcr.2021.06.006","journal-title":"Stem Cell Reports"},{"issue":"1","key":"10931_CR100","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1038\/s41467-021-27464-5","volume":"12","author":"A Fiorenzano","year":"2021","unstructured":"Fiorenzano, A., Sozzi, E., Birtele, M., Kajtez, J., Giacomoni, J., Nilsson, F., et al. (2021). Single-cell transcriptomics captures features of human midbrain development and dopamine neuron diversity in brain organoids. Nature Communications, 12(1), 7302. https:\/\/doi.org\/10.1038\/s41467-021-27464-5","journal-title":"Nature Communications"},{"issue":"7986","key":"10931_CR101","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41586-023-06713-1","volume":"623","author":"DS Park","year":"2023","unstructured":"Park, D. S., Kozaki, T., Tiwari, S. K., Moreira, M., Khalilnezhad, A., Torta, F., et al. (2023). iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer. Nature, 623(7986), 397\u2013405. https:\/\/doi.org\/10.1038\/s41586-023-06713-1","journal-title":"Nature"},{"issue":"7","key":"10931_CR102","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/glia.24167","volume":"70","author":"S Sabate-Soler","year":"2022","unstructured":"Sabate-Soler, S., Nickels, S. L., Saraiva, C., Berger, E., Dubonyte, U., Barmpa, K., et al. (2022). Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality. Glia, 70(7), 1267\u20131288. https:\/\/doi.org\/10.1002\/glia.24167","journal-title":"Glia"},{"issue":"2","key":"10931_CR103","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ajhg.2021.12.009","volume":"109","author":"A Zagare","year":"2022","unstructured":"Zagare, A., Barmpa, K., Smajic, S., Smits, L. M., Grzyb, K., Gr\u00fcnewald, A., et al. (2022). Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. American Journal of Human Genetics, 109(2), 311\u2013327. https:\/\/doi.org\/10.1016\/j.ajhg.2021.12.009","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10931_CR104","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1038\/s41467-022-34005-1","volume":"13","author":"HD Rickner","year":"2022","unstructured":"Rickner, H. D., Jiang, L., Hong, R., O\u2019Neill, N. K., Mojica, C. A., Snyder, B. J., et al. (2022). Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model. Nature Communications, 13(1), 6275. https:\/\/doi.org\/10.1038\/s41467-022-34005-1","journal-title":"Nature Communications"},{"issue":"1","key":"10931_CR105","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41467-024-44732-2","volume":"15","author":"G Morrone Parfitt","year":"2024","unstructured":"Morrone Parfitt, G., Coccia, E., Goldman, C., Whitney, K., Reyes, R., Sarrafha, L., et al. (2024). Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset parkinson\u2019s disease model. Nature Communications, 15(1), 447. https:\/\/doi.org\/10.1038\/s41467-024-44732-2","journal-title":"Nature Communications"},{"issue":"2","key":"10931_CR106","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo, J., Xiao, Y., Sun, A. X., Cukuroglu, E., Tran, H. D., G\u00f6ke, J., et al. (2016). Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and Neuromelanin-Producing neurons. Cell Stem Cell, 19(2), 248\u2013257. https:\/\/doi.org\/10.1016\/j.stem.2016.07.005","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10931_CR107","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.stem.2019.08.002","volume":"25","author":"C Trujillo","year":"2019","unstructured":"Trujillo, C., Gao, R., Negraes, P., Gu, J., Buchanan, J., Preissl, S., et al. (2019). Complex oscillatory waves emerging from cortical organoids model early human brain network development. Cell Stem Cell, 25(4), 558\u2013569e557. https:\/\/doi.org\/10.1016\/j.stem.2019.08.002","journal-title":"Cell Stem Cell"},{"issue":"7336","key":"10931_CR108","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/nature09805","volume":"471","author":"A Gore","year":"2011","unstructured":"Gore, A., Li, Z., Fung, H. L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., et al. (2011). Somatic coding mutations in human induced pluripotent stem cells. Nature, 471(7336), 63\u201367. https:\/\/doi.org\/10.1038\/nature09805","journal-title":"Nature"},{"issue":"7467","key":"10931_CR109","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A., Renner, M., Martin, C. A., Wenzel, D., Bicknell, L. S., Hurles, M. E., et al. (2013). Cerebral organoids model human brain development and microcephaly. Nature, 501(7467), 373\u2013379. https:\/\/doi.org\/10.1038\/nature12517","journal-title":"Nature"},{"issue":"2","key":"10931_CR110","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/bit.28606","volume":"121","author":"P Acharya","year":"2024","unstructured":"Acharya, P., Choi, N. Y., Shrestha, S., Jeong, S., & Lee, M. Y. (2024). Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics. Biotechnology and Bioengineering, 121(2), 489\u2013506. https:\/\/doi.org\/10.1002\/bit.28606","journal-title":"Biotechnology and Bioengineering"},{"key":"10931_CR111","doi-asserted-by":"publisher","unstructured":"Javaherian, A., & Kriegstein, A. (2009). A stem cell niche for intermediate progenitor cells of the embryonic cortex. Cerebral cortex (New York, NY: 1991), 19 Suppl 1 (Suppl 1), i70-77. https:\/\/doi.org\/10.1093\/cercor\/bhp029","DOI":"10.1093\/cercor\/bhp029"},{"issue":"1","key":"10931_CR112","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40035-023-00363-z","volume":"12","author":"A Drobny","year":"2023","unstructured":"Drobny, A., Boros, F. A., Balta, D., Prieto Huarcaya, S., Caylioglu, D., Qazi, N., et al. (2023). Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models. Translational Neurodegeneration, 12(1), 31. https:\/\/doi.org\/10.1186\/s40035-023-00363-z","journal-title":"Translational Neurodegeneration"},{"issue":"1","key":"10931_CR113","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41467-023-37454-4","volume":"14","author":"P Baden","year":"2023","unstructured":"Baden, P., Perez, M. J., Raji, H., Bertoli, F., Kalb, S., Illescas, M., et al. (2023). Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism. Nature Communications, 14(1), 1930. https:\/\/doi.org\/10.1038\/s41467-023-37454-4","journal-title":"Nature Communications"},{"issue":"2","key":"10931_CR114","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano, H., & Morimoto, S. (2022). iPSC-based disease modeling and drug discovery in Cardinal neurodegenerative disorders. Cell Stem Cell, 29(2), 189\u2013208. https:\/\/doi.org\/10.1016\/j.stem.2022.01.007","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10931_CR115","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis, J., Cai, H., & Shi, Y. (2024). Induced pluripotent stem cells (iPSCs): Molecular mechanisms of induction and applications. Signal Transduction and Targeted Therapy, 9(1), 112. https:\/\/doi.org\/10.1038\/s41392-024-01809-0","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10931_CR116","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2022.05.001","volume":"45","author":"A Bose","year":"2022","unstructured":"Bose, A., Petsko, G. A., & Studer, L. (2022). Induced pluripotent stem cells: A tool for modeling parkinson\u2019s disease. Trends in Neurosciences, 45(8), 608\u2013620. https:\/\/doi.org\/10.1016\/j.tins.2022.05.001","journal-title":"Trends in Neurosciences"},{"issue":"21","key":"10931_CR117","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1016\/j.neuron.2021.08.003","volume":"109","author":"VN Lagomarsino","year":"2021","unstructured":"Lagomarsino, V. N., Pearse, R. V. 2nd, Liu, L., Hsieh, Y. C., Fernandez, M. A., Vinton, E. A., et al. (2021). Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors. Neuron, 109(21), 3402\u20133420e3409. https:\/\/doi.org\/10.1016\/j.neuron.2021.08.003","journal-title":"Neuron"},{"issue":"9","key":"10931_CR118","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","volume":"28","author":"J Mertens","year":"2021","unstructured":"Mertens, J., Herdy, J. R., Traxler, L., Schafer, S. T., Schlachetzki, J. C. M., B\u00f6hnke, L., et al. (2021). Age-dependent instability of mature neuronal fate in induced neurons from alzheimer\u2019s patients. Cell Stem Cell, 28(9), 1533\u20131548e1536. https:\/\/doi.org\/10.1016\/j.stem.2021.04.004","journal-title":"Cell Stem Cell"},{"key":"10931_CR119","doi-asserted-by":"publisher","unstructured":"Yeap, Y. J., Teddy, T. J. W., Lee, M. J., Goh, M., & Lim, K. L. (2023). From 2D to 3D: Development of Monolayer Dopaminergic Neuronal and Midbrain Organoid Cultures for Parkinson\u2019s Disease Modeling and Regenerative Therapy. International Journal of Molecular Sciences, 24(3). https:\/\/doi.org\/10.3390\/ijms24032523","DOI":"10.3390\/ijms24032523"},{"issue":"1","key":"10931_CR120","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s13287-021-02369-8","volume":"12","author":"OS Agboola","year":"2021","unstructured":"Agboola, O. S., Hu, X., Shan, Z., Wu, Y., & Lei, L. (2021). Brain organoid: A 3D technology for investigating cellular composition and interactions in human neurological development and disease models in vitro. Stem Cell Research & Therapy, 12(1), 430. https:\/\/doi.org\/10.1186\/s13287-021-02369-8","journal-title":"Stem Cell Research & Therapy"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-025-10931-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-025-10931-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T04:29:57Z","timestamp":1756873797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-025-10931-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":120,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10931"],"URL":"https:\/\/doi.org\/10.1007\/s12015-025-10931-7","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"19 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}